Humacyte, Inc.
Bioengineering off-the-shelf human tissues for vascular repair and regenerative medicine.
HUMA | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 2525 EAST NORTH CAROLINA HIGHWAY 54, 27713 DURHAM
- Website:
- https://humacyte.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Humacyte, Inc. is a biotechnology company pioneering the development and commercial-scale manufacturing of universally implantable, bioengineered human tissues. The company's proprietary platform technology produces regenerative, 'off-the-shelf' acellular tissues designed to treat a wide range of diseases, injuries, and chronic conditions. Through a decellularization process, these tissues are stripped of cellular components to avoid immune rejection, allowing them to be repopulated by the patient's own cells post-implantation. Humacyte's foundational product is the Human Acellular Vessel (HAV), a bioengineered vessel approved by the U.S. FDA for use in vascular trauma repair, with an extensive pipeline of other investigational candidates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Humacyte, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Humacyte, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Humacyte, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
